Close Menu

Ambion has been around for 17 years, but the decision to sell it came down to 30 seconds, recalls Bruce Leander, president of the Austin, Texas-based company. Leander says that last July, Ambion founder Matt Winkler stepped into his office and was mulling over the idea of starting up a diagnostic company, and wondering how to get funding for it. "He said, ‘What do you think about selling Ambion?'" Leander says. "I thought about it for half a minute and I said, ‘I think that's a great idea.'"

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Science reports that MD Anderson Cancer Center has dismissed three researchers over foreign tie concerns.

The New York Times Magazine examines gender discrimination at the Salk Institute.

A second death in gene therapy trial for type 1 spinal muscular atrophy is under investigation, according to Reuters.

In PLOS this week: antibiotic resistance patterns in Escherichia coli, a dozen genetic loci tied to varicose vein risk, and more.